153
Participants
Start Date
January 21, 2019
Primary Completion Date
December 17, 2019
Study Completion Date
December 21, 2019
SK-1403
Patients receive SK-1403 three times a week administered by intravenous bolus injection at the end of each hemodialysis for the whole treatment periods (24 weeks), with individual dose adjustment.
Placebo
Patients receive Placebo three times a week administered by intravenous bolus injection at the end of each hemodialysis for the whole treatment periods (24 weeks), with individual dose adjustment.
Investigational site (there may be other sites in this country), Tokyo
Sanwa Kagaku Kenkyusho Co., Ltd.
INDUSTRY